Table 5: Characterization and comparison of the gram-positive bacteria and antibiotics.

Antibiotics

Results

N

%

P-value*

Ampicillin

Resistant

16

59,26

0,442

 

Sensitive

11

40,74

 

Ampicillin/Sulbactam

Resistant

12

70,59

0,143

 

Sensitive

5

29,41

 

Amoxicillin/ Clavulanic acid

Resistant

13

76,47

0,049

 

Sensitive

4

23,53

 

Cefoxitin

Resistant

0

0,00

0,250

 

Sensitive

3

100,00

 

Ceftriaxone

Resistant

15

78,95

0,019

 

Sensitive

4

21,05

 

Ciprofloxacin

Resistant

13

43,33

0,585

 

Sensitive

17

56,67

 

Clindamycin

Resistant

15

60,00

0,424

 

Sensitive

10

40,00

 

Daptomycin

Resistant

0

0,00

< 0,001

 

Sensitive

22

100,00

 

Erythromycin

Resistant

24

77,42

0,003

 

Sensitive

7

22,58

 

Streptomycin

Resistant

3

100,00

0,250

 

Sensitive

0

0,00

 

Streptomycin of high-level

Resistant

2

28,57

0,453

 

Sensitive

5

71,43

 

Gentamicin

Resistant

12

48,00

0,999

 

Sensitive

13

52,00

 

Gentamicin of high-level

Resistant

1

14,29

0,125

 

Sensitive

6

85,71

 

Levofloxacin

Resistant

12

40,00

0,362

 

Sensitive

18

60,00

 

Linezolid

Resistant

8

25,81

0,011

 

Sensitive

23

74,19

 

Nitrofurantoin

Resistant

2

33,33

0,688

 

Sensitive

4

66,67

 

Norfloxacin

Resistant

2

33,33

0,688

 

Sensitive

4

66,67

 

Oxacillin

Resistant

12

70,59

0,143

 

Sensitive

5

29,41

 

Penicillin

Resistant

19

57,58

0,487

 

Sensitive

14

42,42

 

Rifampicin

Resistant

7

29,17

0,064

 

Sensitive

17

70,83

 

Sulfamethoxazole- trimethoprim

Resistant

7

36,84

0,359

 

Sensitive

12

63,16

 

Sulfazotrim

Resistant

2

66,67

0,999

 

Sensitive

1

33,33

 

Synercid

Resistant

10

38,46

0,327

 

Sensitive

16

61,54

 

Tetracycline

Resistant

12

37,50

0,215

 

Sensitive

20

62,50

 

Teicoplanin

Resistant

3

10,00

< 0,001

 

Sensitive

27

90,00

 

Vancomycin

Resistant

0

0,00

< 0,001

 

Sensitive

33

100,00

 

(*) Binomial test (statistically significant if p < 0,05).